Collegium Medicum, Jan Kochanowski University in Kielce, Kielce, Poland.
3rd Department of Internal Diseases and Cardiology, Warsaw Medical University, Warszawa, Poland.
Kardiol Pol. 2023;81(2):207-214. doi: 10.33963/KP.a2023.0022.
The diagnosis of metabolic associated fatty liver disease (MAFLD) is significant for patients' prognosis, as the disease accelerates the development of cardiovascular complications and, on the other hand, cardiometabolic conditions are risk factors for the development of fatty liver diseases. This expert opinion presents principles of MAFLD diagnosis and standards of management to reduce cardiovascular risks in patients with MAFLD.
代谢相关脂肪性肝病（MAFLD）的诊断对患者的预后具有重要意义，因为该疾病会加速心血管并发症的发展，另一方面，心血管代谢状况也是脂肪性肝病发展的危险因素。本专家意见介绍了 MAFLD 的诊断原则和管理标准，以降低 MAFLD 患者的心血管风险。
